Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InstitutionJefferies Group LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Jefferies Group LLC ownership in APLS / Apellis Pharmaceuticals, Inc.

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Apellis Pharmaceuticals, Inc. (US:APLS) valued at $0 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 11,214 shares of Apellis Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (APLS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

APLS / Apellis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 0 -11,214 -100.00 0 -100.00
2022-11-14 2022-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -33,642 0
2023-09-21 2022-06-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 11,214 10,457 1,381.37 507 1,234.21 0.0042
2022-08-15 2022-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 33,642 32,885 1,521 0.0119
2023-09-21 2022-03-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 757 757 38 0.0002
2022-05-16 2022-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 1,514 1,514 77 0.0004
2023-09-21 2021-12-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 0 -165,038 -100.00 0 -100.00
2022-02-12 2021-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -165,038 0
2023-09-21 2021-09-30 13F/A-2 APELLIS PHARMACEUTICALS COM 03753U106 165,038 -344,091 -67.58 5,440 -83.10 0.0397
2021-12-17 2021-09-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 165,038 -829,039 5,440 0.0374
2021-11-15 2021-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 888,104 -105,973 29,272 0.1889
2023-09-21 2021-06-30 13F/A-2 APELLIS PHARMACEUTICALS COM 03753U106 509,129 492,996 3,055.82 32,177 4,549.71 0.2026
2021-08-20 2021-06-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 994,077 977,944 62,826 0.3720
2021-08-16 2021-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 994,077 977,944 62,826 0.3719
2023-09-21 2021-03-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 16,133 16,133 692 0.0061
2021-05-14 2021-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 16,133 16,133 692 0.0061
2020-11-13 2020-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -70,976 -100.00 0 -100.00
2020-11-02 2020-06-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 70,976 58,515 469.59 2,318 594.01 0.0273
2020-08-14 2020-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 70,976 58,515 2,318 31,148.9473
2020-05-15 2020-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 12,461 12,461 -82.44 334 -85.59 0.0041
2020-02-13 2019-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -13,429 -100.00 0 -100.00
2019-11-13 2019-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 13,429 13,429 324 0.0025
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A APELLIS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F APELLIS PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2023-09-21 2022-06-30 13F/A APELLIS PHARMACEUTICALS COM Call 16,400 0.00 742 -11.04 n/a n/a n/a
2022-08-15 2022-06-30 13F APELLIS PHARMACEUTICALS COM Call 32,800 1,483 n/a n/a n/a
2023-09-21 2022-03-31 13F/A APELLIS PHARMACEUTICALS COM Call 16,400 833 n/a n/a n/a
2022-05-16 2022-03-31 13F APELLIS PHARMACEUTICALS COM Call 32,800 1,667 n/a n/a n/a
2023-09-21 2021-12-31 13F/A APELLIS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-12 2021-12-31 13F APELLIS PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2021-12-17 2021-09-30 13F/A APELLIS PHARMACEUTICALS COM Call 332,900 10,972 n/a n/a n/a
2023-09-21 2021-09-30 13F/A APELLIS PHARMACEUTICALS COM Call 332,900 323.54 10,972 120.90 n/a n/a n/a
2021-11-15 2021-09-30 13F APELLIS PHARMACEUTICALS COM Call 332,900 10,972 n/a n/a n/a
2021-08-20 2021-06-30 13F/A APELLIS PHARMACEUTICALS COM Call 78,600 4,968 n/a n/a n/a
2023-09-21 2021-06-30 13F/A APELLIS PHARMACEUTICALS COM Call 78,600 4,968 n/a n/a n/a
2021-08-16 2021-06-30 13F APELLIS PHARMACEUTICALS COM Call 7,860,000 4,968 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2021-12-31 13F/A APELLIS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-12 2021-12-31 13F APELLIS PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2021-12-17 2021-09-30 13F/A APELLIS PHARMACEUTICALS COM Put 349,000 11,503 n/a n/a n/a
2023-09-21 2021-09-30 13F/A APELLIS PHARMACEUTICALS COM Put 349,000 485.57 11,503 205.44 n/a n/a n/a
2021-11-15 2021-09-30 13F APELLIS PHARMACEUTICALS COM Put 349,000 11,503 n/a n/a n/a
2021-08-20 2021-06-30 13F/A APELLIS PHARMACEUTICALS COM Put 59,600 3,767 n/a n/a n/a
2023-09-21 2021-06-30 13F/A APELLIS PHARMACEUTICALS COM Put 59,600 3,767 n/a n/a n/a
2021-08-16 2021-06-30 13F APELLIS PHARMACEUTICALS COM Put 5,960,000 3,767 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.